Burman Robert, Strömstedt Adam A, Malmsten Martin, Göransson Ulf
Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Biochim Biophys Acta. 2011 Nov;1808(11):2665-73. doi: 10.1016/j.bbamem.2011.07.004. Epub 2011 Jul 20.
The cyclotide family of plant-derived peptides is defined by a cyclic backbone and three disulfide bonds locked into a cyclic cystine knot. They display a diverse range of biological activities, many of which have been linked to an ability to target biological membranes. In the current work, we show that membrane binding and disrupting properties of prototypic cyclotides are dependent on lipid composition, using neutral (zwitterionic) membranes with or without cholesterol and/or anionic lipids. Cycloviolacin O2 (cyO2) caused potent membrane disruption, and showed selectivity towards anionic membranes, whereas kalata B1 and kalata B2 cyclotides were significantly less lytic towards all tested model membranes. To investigate the role of the charged amino acids of cyO2 in the membrane selectivity, these were neutralized using chemical modifications. In contrast to previous studies on the cytotoxic and antimicrobial effects of these derivatives, the Glu6 methyl ester of cyO2 was more potent than the native peptide. However, using membranes of Escherichia coli lipids gave the opposite result: the activity of the native peptide increased 50-fold. By using a combination of ellipsometry and LC-MS, we demonstrated that this unusual membrane specificity is due to native cyO2 extracting preferentially phosphatidylethanolamine-lipids from the membrane, i.e., PE-C16:0/cyC17:0 and PE-C16:0/C18:1.
植物源环肽家族由一个环状主链和三个锁定在环状胱氨酸结中的二硫键定义。它们表现出多种生物活性,其中许多活性与靶向生物膜的能力有关。在当前的研究中,我们使用含有或不含胆固醇和/或阴离子脂质的中性(两性离子)膜,表明原型环肽的膜结合和破坏特性取决于脂质组成。环紫罗兰素O2(cyO2)引起强烈的膜破坏,并对阴离子膜表现出选择性,而卡拉塔B1和卡拉塔B2环肽对所有测试的模型膜的裂解作用明显较弱。为了研究cyO2中带电荷氨基酸在膜选择性中的作用,我们通过化学修饰将这些氨基酸中和。与之前关于这些衍生物的细胞毒性和抗菌作用的研究相反,cyO2的Glu6甲酯比天然肽更有效。然而,使用大肠杆菌脂质膜时得到了相反的结果:天然肽的活性增加了50倍。通过结合椭偏仪和液相色谱-质谱联用技术,我们证明这种不寻常的膜特异性是由于天然cyO2优先从膜中提取磷脂酰乙醇胺脂质,即PE-C16:0/cyC17:0和PE-C16:0/C18:1。